Ratings by Piper Sandler (Matt O'Brien)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/12/2026 | Boston Scientific | BSX | Maintain | Overweight (N/A) |
|
Details | ||
| 5/8/2026 | Shoulder Innovations | SI | Maintain | Overweight (N/A) |
|
Details | ||
| 5/6/2026 | TransMedics Group | TMDX | Maintain | Overweight (N/A) |
|
Details | ||
| 5/1/2026 | Integer Holding | ITGR | Maintain | Overweight (N/A) |
|
Details | ||
| 4/30/2026 | Procept BioRobotics Corp | PRCT | Maintain | Overweight (N/A) |
|
Details | ||
| 2/25/2026 | TransMedics Group | TMDX | Maintain | Overweight (N/A) |
|
Details | ||
| 2/20/2026 | Tandem Diabetes Care | TNDM | Maintain | Neutral (N/A) |
|
Details | ||
| 11/6/2025 | CONMED | CNMD | Maintain | Overweight (N/A) |
|
Details | ||
| 11/5/2025 | Procept BioRobotics Corp | PRCT | Maintain | Overweight (N/A) |
|
Details | ||
| 10/31/2025 | DexCom | DXCM | Maintain | (N/A) |
|
Details | ||
| 10/30/2025 | TransMedics Group | TMDX | Maintain | Overweight (N/A) |
|
Details | ||
| 10/30/2025 | TransMedics Group | TMDX | Maintain | Overweight (N/A) |
|
Details | ||
| 8/7/2025 | Procept BioRobotics Corp | PRCT | Maintain | Overweight (N/A) |
|
Details | ||
| 7/31/2025 | DexCom | DXCM | Maintain | Overweight (N/A) |
|
Details | ||
| 7/31/2025 | CONMED | CNMD | Maintain | Overweight (N/A) |
|
Details | ||
| 5/9/2025 | TransMedics Group | TMDX | Maintain | Overweight (N/A) |
|
Details | ||
| 5/9/2025 | Globus Medical | GMED | Maintain | Overweight (N/A) |
|
Details | ||
| 5/9/2025 | CVRx Inc | CVRX | Maintain | Overweight (N/A) |
|
Details | ||
| 5/8/2025 | OrthoPediatrics Corp. | KIDS | Maintain | Overweight (N/A) |
|
Details | ||
| 3/6/2025 | Sight Sciences Inc. | SGHT | Maintain | Neutral (N/A) |
|
Details | ||
| 2/27/2025 | Tandem Diabetes Care | TNDM | Maintain | Overweight (N/A) |
|
Details | ||
| 2/21/2025 | Insulet Corporation | PODD | Maintain | Overweight (N/A) |
|
Details | ||
| 2/14/2025 | Avita Medical Ltd. | RCEL | Maintain | Neutral (N/A) |
|
Details | ||
| 2/14/2025 | DexCom | DXCM | Maintain | Overweight (N/A) |
|
Details | ||
| 2/5/2025 | CVRx Inc | CVRX | Maintain | Overweight (N/A) |
|
Details | ||
| 2/3/2025 | Boston Scientific | BSX | Maintain | Overweight (N/A) |
|
Details | ||
| 7/1/2024 | Teleflex | TFX | Upgrade | Overweight (Neutral) |
207.23 (177.63) |
-14.28% | Details | |
| 5/14/2024 | Avita Medical Ltd. | RCEL | Downgrade | Neutral (Overweight) |
8.26 (3.92) |
-52.54% | Details | |
| 3/22/2024 | TELA Bio, Inc. | TELA | Maintain | Overweight (N/A) |
|
Details | ||
| 3/8/2024 | Humacyte | HUMA | Maintain | Neutral (N/A) |
|
Details | ||
| 3/1/2024 | Cooper Companies | COO | Maintain | Overweight (N/A) |
|
Details | ||
| 2/23/2024 | Avita Medical Ltd. | RCEL | Maintain | Overweight (N/A) |
|
Details | ||
| 2/23/2024 | Penumbra | PEN | Maintain | Overweight (N/A) |
|
Details | ||
| 2/1/2024 | CONMED | CNMD | Maintain | Overweight (N/A) |
|
Details | ||
| 1/26/2024 | CVRx Inc | CVRX | Maintain | Overweight (N/A) |
|
Details | ||
| 1/12/2024 | Cooper Companies | COO | Maintain | Overweight (N/A) |
|
Details | ||
| 12/22/2023 | Glaukos Corporation | GKOS | Maintain | Overweight (N/A) |
|
Details | ||
| 12/19/2023 | DexCom | DXCM | Maintain | Overweight (N/A) |
|
Details | ||
| 11/14/2023 | Minerva | UTRS | Maintain | Overweight (N/A) |
|
Details | ||
| 11/14/2023 | Orchestra BioMed Inc. | OBIO | Maintain | Overweight (N/A) |
|
Details | ||
| 11/10/2023 | Avita Medical Ltd. | RCEL | Maintain | Overweight (N/A) |
|
Details | ||
| 11/10/2023 | Humacyte | HUMA | Maintain | Neutral (N/A) |
|
Details | ||
| 11/9/2023 | Apyx Medical Corp. | APYX | Downgrade | Neutral (Overweight) |
2.07 (4.08) |
97.1% | Details | |
| 11/9/2023 | Cutera | CUTR | Maintain | Neutral (N/A) |
|
Details | ||
| 11/6/2023 | Teleflex | TFX | Maintain | Neutral (N/A) |
|
Details | ||
| 11/3/2023 | Penumbra | PEN | Maintain | Overweight (N/A) |
|
Details | ||
| 11/2/2023 | Tandem Diabetes Care | TNDM | Maintain | Overweight (N/A) |
|
Details | ||
| 10/27/2023 | Merit Medical Systems, Inc. | MMSI | Maintain | Overweight (N/A) |
|
Details | ||
| 10/27/2023 | DexCom | DXCM | Maintain | Overweight (N/A) |
|
Details | ||
| 10/26/2023 | CONMED | CNMD | Maintain | Overweight (N/A) |
|
Details | ||
| 9/25/2023 | Teleflex | TFX | Maintain | Neutral (N/A) |
|
Details | ||
| 9/12/2023 | Sight Sciences Inc. | SGHT | Downgrade | Neutral (Overweight) |
6.14 (5.41) |
-11.89% | Details | |
| 8/14/2023 | Humacyte | HUMA | Upgrade | Neutral (Underweight) |
3.27 (0.70) |
-78.59% | Details | |
| 8/11/2023 | Procept BioRobotics Corp | PRCT | New Coverage | Overweight (N/A) |
31.61 (20.60) |
-34.83% | Details | |
| 7/27/2023 | Cutera | CUTR | Upgrade | Neutral (Underweight) |
14.85 (0.10) |
-99.33% | Details | |
| 7/6/2023 | Boston Scientific | BSX | Maintain | Overweight (N/A) |
|
Details | ||
| 6/7/2023 | Glaukos Corporation | GKOS | Upgrade | Overweight (Neutral) |
62.61 (134.65) |
115.06% | Details | |
| 5/12/2023 | Avita Medical Ltd. | RCEL | Maintain | Overweight (N/A) |
|
Details | ||
| 5/12/2023 | Apyx Medical Corp. | APYX | Maintain | Overweight (N/A) |
|
Details | ||
| 5/10/2023 | Cutera | CUTR | New Coverage | Underweight (N/A) |
20.67 (0.10) |
-99.52% | Details | |
| 4/27/2023 | Boston Scientific | BSX | Maintain | Overweight (N/A) |
|
Details | ||
| 4/27/2023 | CONMED | CNMD | Maintain | Overweight (N/A) |
|
Details | ||
| 3/2/2023 | OrthoPediatrics Corp. | KIDS | Maintain | Overweight (N/A) |
|
Details | ||
| 3/1/2023 | Cutera | CUTR | Maintain | Overweight (N/A) |
|
Details | ||
| 2/24/2023 | Integer Holding | ITGR | New Coverage | Overweight (N/A) |
73.68 (89.54) |
21.53% | Details | |
| 2/24/2023 | Orchestra BioMed Inc. | OBIO | New Coverage | Overweight (N/A) |
9.51 (4.04) |
-57.52% | Details | |
| 2/23/2023 | Tandem Diabetes Care | TNDM | Maintain | Overweight (N/A) |
|
Details | ||
| 2/23/2023 | Glaukos Corporation | GKOS | Maintain | Neutral (N/A) |
|
Details | ||
| 2/23/2023 | Merit Medical Systems, Inc. | MMSI | Maintain | Overweight (N/A) |
|
Details | ||
| 2/15/2023 | Globus Medical | GMED | Maintain | Neutral (N/A) |
|
Details | ||
| 2/10/2023 | CVRx Inc | CVRX | Maintain | Overweight (N/A) |
|
Details | ||
| 2/9/2023 | Globus Medical | GMED | Downgrade | Neutral (Overweight) |
76.96 (63.95) |
-16.9% | Details | |
| 2/9/2023 | NuVasive | NUVA | Downgrade | Neutral (Overweight) |
45.78 (39.75) |
-13.17% | Details | |
| 2/3/2023 | CONMED | CNMD | Maintain | Overweight (N/A) |
|
Details | ||
| 2/1/2023 | Stryker | SYK | Maintain | Overweight (N/A) |
|
Details | ||
| 1/30/2023 | Penumbra | PEN | New Coverage | Overweight (N/A) |
244.58 (313.43) |
28.15% | Details | |
| 1/6/2023 | Zynex Inc. | ZYXI | Upgrade | Overweight (Neutral) |
14.11 (0.13) |
-99.08% | Details | |
| 12/15/2022 | DexCom | DXCM | Maintain | Overweight (N/A) |
|
Details | ||
| 12/9/2022 | Cooper Companies | COO | Maintain | Overweight (N/A) |
|
Details | ||
| 11/15/2022 | Motus GI Holdings | MOTS | Maintain | Overweight (N/A) |
|
Details | ||
| 11/15/2022 | Miromatrix Medical inc. | MIRO | Maintain | Overweight (N/A) |
|
Details | ||
| 11/11/2022 | Paragon 28, Inc | FNA | Maintain | Overweight (N/A) |
|
Details | ||
| 11/10/2022 | TELA Bio, Inc. | TELA | Maintain | Overweight (N/A) |
|
Details | ||
| 11/10/2022 | NuVasive | NUVA | Maintain | Overweight (N/A) |
|
Details | ||
| 11/3/2022 | Tandem Diabetes Care | TNDM | Maintain | Overweight (N/A) |
|
Details | ||
| 11/3/2022 | Glaukos Corporation | GKOS | Maintain | Neutral (N/A) |
|
Details | ||
| 11/3/2022 | Cooper Companies | COO | Maintain | Overweight (N/A) |
|
Details | ||
| 11/2/2022 | ViewRay Inc. | VRAY | Maintain | Overweight (N/A) |
|
Details | ||
| 11/2/2022 | CVRx Inc | CVRX | Maintain | Overweight (N/A) |
|
Details | ||
| 11/1/2022 | ABIOMED | ABMD | Downgrade | Neutral (Overweight) |
252.08 (381.02) |
51.15% | Details | |
| 10/28/2022 | Zynex Inc. | ZYXI | Maintain | Neutral (N/A) |
|
Details | ||
| 10/28/2022 | DexCom | DXCM | Maintain | Overweight (N/A) |
|
Details | ||
| 10/27/2022 | Merit Medical Systems, Inc. | MMSI | Maintain | Overweight (N/A) |
|
Details | ||
| 10/27/2022 | CONMED | CNMD | Maintain | Overweight (N/A) |
|
Details | ||
| 10/10/2022 | ABIOMED | ABMD | Maintain | Overweight (N/A) |
|
Details | ||
| 10/10/2022 | Stryker | SYK | Maintain | Overweight (N/A) |
|
Details | ||
| 9/14/2022 | Stryker | SYK | Maintain | Overweight (N/A) |
|
Details | ||
| 9/9/2022 | Boston Scientific | BSX | Maintain | Overweight (N/A) |
|
Details | ||
| 8/31/2022 | Miromatrix Medical inc. | MIRO | New Coverage | Overweight (N/A) |
2.82 (3.39) |
20.21% | Details | |
| 8/12/2022 | Sight Sciences Inc. | SGHT | Maintain | Overweight (N/A) |
|
Details | ||
| 8/12/2022 | Motus GI Holdings | MOTS | Maintain | Overweight (N/A) |
|
Details | ||
| 8/12/2022 | Apyx Medical Corp. | APYX | Maintain | Overweight (N/A) |
|
Details | ||
| 8/10/2022 | Minerva | UTRS | Maintain | Overweight (N/A) |
|
Details | ||
| 8/5/2022 | Globus Medical | GMED | Maintain | Overweight (N/A) |
|
Details | ||
| 8/5/2022 | Cutera | CUTR | Maintain | Overweight (N/A) |
|
Details | ||
| 8/4/2022 | Tandem Diabetes Care | TNDM | Maintain | Overweight (N/A) |
|
Details | ||
| 8/4/2022 | NuVasive | NUVA | Maintain | Overweight (N/A) |
|
Details | ||
| 8/3/2022 | ViewRay Inc. | VRAY | Maintain | Overweight (N/A) |
|
Details | ||
| 8/3/2022 | SeaSpine Holdings | SPNE | Maintain | Overweight (N/A) |
|
Details | ||
| 8/3/2022 | AtriCure Inc. | ATRC | Maintain | Overweight (N/A) |
|
Details | ||
| 7/29/2022 | DexCom | DXCM | Maintain | Overweight (N/A) |
|
Details | ||
| 7/28/2022 | CONMED | CNMD | Maintain | Overweight (N/A) |
|
Details | ||
| 7/27/2022 | Stryker | SYK | Maintain | Overweight (N/A) |
|
Details | ||
| 7/8/2022 | Cooper Companies | COO | Maintain | Overweight (N/A) |
|
Details | ||
| 6/3/2022 | Globus Medical | GMED | Maintain | Overweight (N/A) |
|
Details | ||
| 6/3/2022 | Cooper Companies | COO | Maintain | Overweight (N/A) |
|
Details | ||
| 5/31/2022 | Cooper Companies | COO | Maintain | Overweight (N/A) |
|
Details | ||
| 5/16/2022 | Humacyte | HUMA | Downgrade | Underweight (Neutral) |
5.04 (0.70) |
-86.11% | Details | |
| 5/12/2022 | Minerva | UTRS | Maintain | Overweight (N/A) |
|
Details | ||
| 5/11/2022 | Sight Sciences Inc. | SGHT | Maintain | Overweight (N/A) |
|
Details | ||
| 5/6/2022 | ViewRay Inc. | VRAY | Maintain | Overweight (N/A) |
|
Details | ||
| 5/5/2022 | Tandem Diabetes Care | TNDM | Maintain | Overweight (N/A) |
|
Details | ||
| 4/29/2022 | Stryker | SYK | Maintain | Overweight (N/A) |
|
Details | ||
| 4/29/2022 | DexCom | DXCM | Maintain | Overweight (N/A) |
|
Details | ||
| 4/26/2022 | CVRx Inc | CVRX | Maintain | Overweight (N/A) |
|
Details | ||
| 3/29/2022 | Humacyte | HUMA | Maintain | Overweight (N/A) |
|
Details | ||
| 3/25/2022 | Sight Sciences Inc. | SGHT | Maintain | Overweight (N/A) |
|
Details | ||
| 3/14/2022 | SeaSpine Holdings | SPNE | Maintain | Overweight (N/A) |
|
Details | ||
| 3/9/2022 | Minerva | UTRS | Maintain | Overweight (N/A) |
|
Details | ||
| 3/1/2022 | Avita Medical Ltd. | RCEL | Maintain | Overweight (N/A) |
|
Details | ||
| 2/16/2022 | CVRx Inc | CVRX | Maintain | Overweight (N/A) |
|
Details | ||
| 1/4/2022 | Globus Medical | GMED | Upgrade | Overweight (Neutral) |
72.20 (80.04) |
10.86% | Details | |
| 1/4/2022 | Medtronic, Inc. | MDT | Downgrade | Neutral (Overweight) |
103.45 (80.63) |
-22.06% | Details | |
| 1/4/2022 | Stryker | SYK | Upgrade | Overweight (Neutral) |
267.42 (310.00) |
15.92% | Details | |
| 1/4/2022 | Teleflex | TFX | Downgrade | Neutral (Overweight) |
328.48 (124.26) |
-62.17% | Details | |
| 1/3/2022 | Neuronetics | STIM | Maintain | Overweight (N/A) |
|
Details | ||
| 11/16/2021 | Minerva | UTRS | New Coverage | Overweight (N/A) |
9.68 (0.00) |
-100% | Details | |
| 11/10/2021 | Surgalign Holdings Inc | SRGA | Maintain | Overweight (N/A) |
|
Details | ||
| 11/9/2021 | Avita Medical Ltd. | RCEL | Maintain | Overweight (N/A) |
|
Details | ||
| 11/9/2021 | Paragon 28, Inc | FNA | New Coverage | Overweight (N/A) |
23.95 (13.09) |
-45.34% | Details | |
| 11/5/2021 | Globus Medical | GMED | Maintain | Neutral (N/A) |
|
Details | ||
| 11/5/2021 | Glaukos Corporation | GKOS | Maintain | Neutral (N/A) |
|
Details | ||
| 11/4/2021 | Tandem Diabetes Care | TNDM | Maintain | Overweight (N/A) |
|
Details | ||
| 11/3/2021 | Zynex Inc. | ZYXI | Maintain | Neutral (N/A) |
|
Details | ||
| 11/3/2021 | DexCom | DXCM | Maintain | Overweight (N/A) |
|
Details | ||
| 10/29/2021 | Stryker | SYK | Maintain | Neutral (N/A) |
|
Details | ||
| 10/29/2021 | DexCom | DXCM | Maintain | Overweight (N/A) |
|
Details | ||
| 8/13/2021 | Motus GI Holdings | MOTS | Maintain | Overweight (N/A) |
|
Details | ||
| 8/9/2021 | Intersect ENT | XENT | Maintain | Neutral (N/A) |
|
Details | ||
| 8/9/2021 | Sight Sciences Inc. | SGHT | New Coverage | Overweight (N/A) |
37.94 (5.41) |
-85.74% | Details | |
| 8/6/2021 | Glaukos Corporation | GKOS | Maintain | Neutral (N/A) |
|
Details | ||
| 8/5/2021 | Globus Medical | GMED | Maintain | Neutral (N/A) |
|
Details | ||
| 8/5/2021 | Cutera | CUTR | Maintain | Overweight (N/A) |
|
Details | ||
| 8/5/2021 | AtriCure Inc. | ATRC | Maintain | Overweight (N/A) |
|
Details | ||
| 7/30/2021 | DexCom | DXCM | Maintain | Overweight (N/A) |
|
Details | ||
| 7/30/2021 | Merit Medical Systems, Inc. | MMSI | Maintain | Overweight (N/A) |
|
Details | ||
| 7/28/2021 | Stryker | SYK | Maintain | Neutral (N/A) |
|
Details | ||
| 7/26/2021 | CVRx Inc | CVRX | New Coverage | Overweight (N/A) |
20.33 (5.15) |
-74.67% | Details | |
| 6/1/2021 | Cooper Companies | COO | Maintain | Overweight (N/A) |
|
Details | ||
| 5/6/2021 | NuVasive | NUVA | Maintain | Overweight (N/A) |
|
Details | ||
| 4/29/2021 | CONMED | CNMD | Maintain | Overweight (N/A) |
|
Details | ||
| 4/28/2021 | Stryker | SYK | Maintain | Neutral (N/A) |
|
Details | ||
| 4/6/2021 | OrthoPediatrics Corp. | KIDS | Maintain | Overweight (N/A) |
|
Details | ||
| 3/29/2021 | NuVasive | NUVA | Maintain | Overweight (N/A) |
|
Details | ||
| 3/2/2021 | SeaSpine Holdings | SPNE | Maintain | Overweight (N/A) |
|
Details | ||
| 3/2/2021 | Avita Medical Ltd. | RCEL | New Coverage | Overweight (N/A) |
21.74 (3.92) |
-81.97% | Details | |
| 2/24/2021 | AtriCure Inc. | ATRC | Maintain | Overweight (N/A) |
|
Details | ||
| 2/24/2021 | ArthroCare | ARTC | Maintain | Overweight (N/A) |
|
Details | ||
| 2/18/2021 | Cutera | CUTR | Maintain | Overweight (N/A) |
|
Details | ||
| 2/11/2021 | Cooper Companies | COO | Maintain | Overweight (N/A) |
|
Details | ||
| 2/2/2021 | Surgalign Holdings Inc | SRGA | New Coverage | Overweight (N/A) |
1.68 (0.18) |
-89.29% | Details | |
| 1/29/2021 | Glaukos Corporation | GKOS | Downgrade | Neutral (Overweight) |
90.64 (134.65) |
48.55% | Details | |
| 1/29/2021 | Baxter International | BAX | Downgrade | Neutral (Overweight) |
77.15 (20.10) |
-73.95% | Details | |
| 1/29/2021 | Zynex Inc. | ZYXI | Downgrade | Neutral (Overweight) |
20.29 (0.13) |
-99.36% | Details | |
| 1/21/2021 | Neuronetics | STIM | Maintain | Overweight (N/A) |
|
Details | ||
| 1/12/2021 | ViewRay Inc. | VRAY | Maintain | Overweight (N/A) |
|
Details | ||
| 12/15/2020 | Livanova | LIVN | Maintain | Overweight (N/A) |
|
Details | ||
| 11/24/2020 | Neuronetics | STIM | Maintain | Overweight (N/A) |
|
Details | ||
| 11/6/2020 | ViewRay Inc. | VRAY | Maintain | Overweight (N/A) |
|
Details | ||
| 11/5/2020 | Cutera | CUTR | Maintain | Overweight (N/A) |
|
Details | ||
| 7/30/2020 | CONMED | CNMD | Maintain | Overweight (N/A) |
|
Details | ||
| 7/30/2020 | Merit Medical Systems, Inc. | MMSI | Maintain | Overweight (N/A) |
|
Details | ||
| 7/30/2020 | Boston Scientific | BSX | Downgrade | Neutral (Overweight) |
38.27 (45.60) |
19.15% | Details | |
| 7/29/2020 | DexCom | DXCM | Maintain | Overweight (N/A) |
|
Details | ||
| 7/23/2020 | Align Technology | ALGN | Maintain | Overweight (N/A) |
|
Details | ||
| 7/20/2020 | Zynex Inc. | ZYXI | New Coverage | Overweight (N/A) |
21.30 (0.13) |
-99.39% | Details | |
| 7/6/2020 | Globus Medical | GMED | Downgrade | Neutral (Overweight) |
48.67 (80.04) |
64.45% | Details | |
| 2/28/2020 | Glaukos Corporation | GKOS | Maintain | Overweight (N/A) |
|
Details | ||
| 2/25/2020 | Merit Medical Systems, Inc. | MMSI | Maintain | Overweight (N/A) |
|
Details | ||
| 1/30/2020 | Align Technology | ALGN | Maintain | Overweight (N/A) |
|
Details | ||
| 1/7/2020 | NuVasive | NUVA | Maintain | Overweight (N/A) |
|
Details | ||
| 1/7/2020 | OrthoPediatrics Corp. | KIDS | Maintain | Overweight (N/A) |
|
Details | ||
| 1/7/2020 | CONMED | CNMD | Maintain | Overweight (N/A) |
|
Details | ||
| 11/12/2019 | Apyx Medical Corp. | APYX | Maintain | Overweight (N/A) |
|
Details | ||
| 11/7/2019 | Globus Medical | GMED | Maintain | Overweight (N/A) |
|
Details | ||
| 11/7/2019 | Endologix | ELGX | Maintain | Neutral (N/A) |
|
Details | ||
| 10/31/2019 | NuVasive | NUVA | Maintain | Overweight (N/A) |
|
Details | ||
| 10/31/2019 | Merit Medical Systems, Inc. | MMSI | Maintain | Overweight (N/A) |
|
Details | ||
| 10/31/2019 | CONMED | CNMD | Maintain | Overweight (N/A) |
|
Details |
